97 related articles for article (PubMed ID: 24013048)
1. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction.
Spallarossa P; Guerrini M; Arboscello E; Sicbaldi V
J Am Coll Cardiol; 2013 Dec; 62(25):2451-2452. PubMed ID: 24013048
[No Abstract] [Full Text] [Related]
2. Reply: Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies.
Bosch X; Sitges M; Rovira M; Ortiz-Pérez JT; Esteve J
J Am Coll Cardiol; 2013 Dec; 62(25):2452. PubMed ID: 24013047
[No Abstract] [Full Text] [Related]
3. Enalapril/carvedilol for prevention of chemotherapy-induced heart failure: an end to the problem.
Golwala H
J Am Coll Cardiol; 2013 Dec; 62(25):2450-2451. PubMed ID: 24013049
[No Abstract] [Full Text] [Related]
4. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).
Bosch X; Rovira M; Sitges M; Domènech A; Ortiz-Pérez JT; de Caralt TM; Morales-Ruiz M; Perea RJ; Monzó M; Esteve J
J Am Coll Cardiol; 2013 Jun; 61(23):2355-62. PubMed ID: 23583763
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotection during chemotherapy: need for faster transfer of knowledge from cardiology to oncology and role for a cardio-oncologist.
Smiseth OA; Edvardsen T; Skulstad H
J Am Coll Cardiol; 2013 Jun; 61(23):2363-4. PubMed ID: 23583243
[No Abstract] [Full Text] [Related]
6. Prevention of chemotherapy-induced left ventricular dysfunction with enalapril and carvedilol: rationale and design of the OVERCOME trial.
Bosch X; Esteve J; Sitges M; de Caralt TM; Domènech A; Ortiz JT; Monzó M; Morales-Ruiz M; Perea RJ; Rovira M
J Card Fail; 2011 Aug; 17(8):643-8. PubMed ID: 21807325
[TBL] [Abstract][Full Text] [Related]
7. Preventive role of carvedilol in adriamycin-induced cardiomyopathy.
Jhorawat R; Kumari S; Varma SC; Rohit MK; Narula N; Suri V; Malhotra P; Jain S
Indian J Med Res; 2016 Nov; 144(5):725-729. PubMed ID: 28361826
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
9. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).
Remme WJ; Riegger G; Hildebrandt P; Komajda M; Jaarsma W; Bobbio M; Soler-Soler J; Scherhag A; Lutiger B; Rydén L
Cardiovasc Drugs Ther; 2004 Jan; 18(1):57-66. PubMed ID: 15115904
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of additional low-dose carvedilol in maintenance hemodialysis patients with asymptomatic left ventricular systolic dysfunction].
Nakayama M; Ishii A; Takeguchi F; Nakano H
J Cardiol; 2006 Jun; 47(6):285-91. PubMed ID: 16800371
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction.
Gandhi PS; Goyal RK; Jain AR; Mallya BS; Gupta VM; Shah DS; Trivedi BR; Shastri NA; Mehta CB; Jain KA; Bhavasar NS; Shah UJ
Can J Physiol Pharmacol; 2007 Feb; 85(2):193-9. PubMed ID: 17487260
[TBL] [Abstract][Full Text] [Related]
12. [The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].
Shimamoto K; Kawana M
Nihon Rinsho; 2007 Apr; 65 Suppl 4():531-6. PubMed ID: 17511104
[No Abstract] [Full Text] [Related]
13. Rapid carvedilol up-titration in hospitalized patients with left ventricular systolic dysfunction--data from the Carvedilol in Hospital: Up-titration Limits after Acute Patients Admission registry.
Martínez-Sellés M; Datino T; Alhama M; Barrueco N; Castillo I; Fernández-Avilés F
J Cardiovasc Med (Hagerstown); 2010 May; 11(5):352-8. PubMed ID: 20154635
[TBL] [Abstract][Full Text] [Related]
14. To add amiodarone or not: that is the question.
Zimmerman MJ; Gerson MC
J Nucl Cardiol; 2008; 15(1):7-9. PubMed ID: 18242473
[No Abstract] [Full Text] [Related]
15. Controlled-release carvedilol.
Carter NJ; Keating GM
Am J Cardiovasc Drugs; 2008; 8(4):271-82. PubMed ID: 18690761
[No Abstract] [Full Text] [Related]
16. The effect of carvedilol therapy on myocardial functional reserve in patients with advanced heart failure caused by nonischemic dilated cardiomyopathy.
Paraskevaidis IA; Tsiapras D; Karavolias G; Adamopoulos S; Dodouras T; Cokkinos P; Kremastinos DT
J Am Soc Echocardiogr; 2006 May; 19(5):529-35. PubMed ID: 16644436
[No Abstract] [Full Text] [Related]
17. Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up.
Elitok A; Oz F; Cizgici AY; Kilic L; Ciftci R; Sen F; Bugra Z; Mercanoglu F; Oncul A; Oflaz H
Cardiol J; 2014; 21(5):509-15. PubMed ID: 24142687
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol-Enriched Cold Oxygenated Blood Cardioplegia Improves Left Ventricular Diastolic Function After Weaning From Cardiopulmonary Bypass.
Dahle GO; Salminen PR; Moen CA; Eliassen F; Nygreen E; Kytö V; Saukko P; Haaverstad R; Matre K; Grong K
J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):859-68. PubMed ID: 27521963
[TBL] [Abstract][Full Text] [Related]
19. Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention--the PASSAT Study.
Tölg R; Witt M; Schwarz B; Kurz T; Kurowski V; Hartmann F; Geist V; Richardt G
Clin Res Cardiol; 2006 Jan; 95(1):31-41. PubMed ID: 16598443
[TBL] [Abstract][Full Text] [Related]
20. N-terminal prohormone brain natriuretic peptide plasma levels in heart failure are affected both directly and indirectly by carvedilol.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
Angiology; 2008; 59(3):323-8. PubMed ID: 18388105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
